Mount Sinai experts to educate families on identifying signs, symptoms of ASD

Published on March 30, 2013 at 12:51 AM · No Comments

The latest report from the US Centers for Disease Control and Prevention estimates that one out of 50 school-aged children has an autism spectrum disorder (ASD). Researchers have made great strides in identifying potential causes and treatments for ASD, and experts from the Seaver Autism Center at Mount Sinai are available to educate families on what these advancements are and what signs and symptoms they should watch out for, in honor of Autism Awareness Month.

Joseph D. Buxbaum, PhD, Director of the Seaver Autism Center and Professor of Psychiatry, Genetics and Genomic Sciences, and Neuroscience, says, "Early diagnosis is absolutely critical, because the earlier we diagnose an autism spectrum disorder, the earlier we can begin treatment. If you have concerns about your child, you should see a specialist for a more thorough evaluation."

The American Academy of Pediatrics recommends that all children be screened for autism at their 18- and 24-month well-baby check-ups. The most common early symptoms, which present as early as 18 months, include: fleeting eye contact; limited gesturing (pointing, waving good-bye); limited pretend play; difficulty reading nonverbal cues; difficulty taking others' perspectives; odd language; repetitive motor and object play; difficulties with changes in environment/routine.

Clinicians use behavioral and learning assessment tools to diagnose autism. There is currently no medical test to diagnose ASD. The current treatment is intensive, comprehensive behavioral training starting in early childhood.

The Seaver Autism Center is leading an international effort to find the genetic causes and treatments for ASD. Dr. Buxbaum established the Autism Sequencing Consortium (ASC), an international group of researchers whose goal is to facilitate the collection and analysis of whole exome sequence data (the segments of DNA that code for specific proteins) from as many as 10,000 individuals with autism and 30,000 individuals overall, with the eventual aim of contributing to improved treatments.

Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | 繁體中文 | Nederlands | Русский | Svenska | Polski
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment